Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and acceptably safe for the treatment of type 2 diabetes and obesity, leading to ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

New potential therapeutic targets have been identified for diabetic kidney disease, the leading cause of kidney failure ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD)—the leading cause of kidney failure ...

Genetic image of the kidneys New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the ...

An investigation led by Brigham and Women's Hospital finds empagliflozin (sold as Jardiance) may reduce the risk of diabetic ...

Kidney complications has become a rising concern in the health sector. Here are common everyday habits that are probably risking your kidney.

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...

Understanding what causes type 2 diabetes is crucial. This chronic condition occurs when your body doesn't produce enough ...

This Diabetes Heart Connection Day we explore how management of diabetes and cardiovascular care often go hand in hand.

CORE Kidney, a patient support and advocacy group that helps patients with kidney disease navigate their complex journey, today announced its collaboration with Boehringer Ingelheim and Eli Lilly and ...